Cargando…

30. The paradox

INTRODUCTION: Incidental findings on investigations is not uncommon in rheumatology practice. Here such an incidental finding has led to dramatic change in the management of the underlying disease. CASE DESCRIPTION: A 38-year-old gentleman known to have ankylosing spondylitis (AS) since 2008, with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Mohammed, Jenkins, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761446/
http://dx.doi.org/10.1093/rap/rkz029.006
_version_ 1783454035650543616
author Saleh, Mohammed
Jenkins, Charlotte
author_facet Saleh, Mohammed
Jenkins, Charlotte
author_sort Saleh, Mohammed
collection PubMed
description INTRODUCTION: Incidental findings on investigations is not uncommon in rheumatology practice. Here such an incidental finding has led to dramatic change in the management of the underlying disease. CASE DESCRIPTION: A 38-year-old gentleman known to have ankylosing spondylitis (AS) since 2008, with radiologically evident sacroilitis on X-ray and MRI, was reviewed routinely in clinic and reported pain and restriction of neck movement and subsequent MRI cervical spine in April 2017 has shown incidental finding of apical fibrosis, but no AS activity. He denied constitutional and respiratory symptoms apart from occasional dry cough. Chest X-ray and high resolution CT scan confirmed the same findings of apical fibrosis in addition to bilateral reticulonodular and fisural changes. Blood tests showed angiotensin converting Eezyme level ACE 65 U/L (normal range 8-65), C-reactive protein <5. Bronchoscopy/biopsy showed non-caseating epitheliod granuloma. ZN stain and culture showed no TB infection. He was reviewed by the respiratory team and felt findings could conceivably fit with sarcoidosis. His dry cough has improved after Benepali was discontinued in June 2017 and no steroids were given. However, had a flare of AS symptoms (ribs and lower back pain and stiffness, right SIJ pain) despite regular etoricoxib and required to start on secukinumab. DISCUSSION: Benepali (Etanercept biosimilar) sounds not different from the originator biologic in causing sarcoid-like reactions commonly present as skin rash and lung lesions. Etanercept is associated with a large majority of reported anti-TNF induced sarcoid-like cases, not effective in treating sarcoidosis and may even exacerbate it. However, there are few reports of adalimumab induced sarcoid-like reactions that resolved when treated with etanercept. Paradoxical reaction to one TNF alfa inhibitor does not preclude the use of other TNF blocking agents including etanercept. KEY LEARNING POINTS: Lung lesions after exposure to anti-TNF warrants investigating a wide range of differential diagnoses. Paradoxical sarcoid-like reactions can occur with anti-TNF treatment and resolves on discounting it. Alternative biologic in ankylosing spondylitis might be a challenge. CONFLICTS OF INTEREST: The authors have declared no conflicts of interest.
format Online
Article
Text
id pubmed-6761446
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-67614462019-10-02 30. The paradox Saleh, Mohammed Jenkins, Charlotte Rheumatol Adv Pract POSTER PRESENTATIONS INTRODUCTION: Incidental findings on investigations is not uncommon in rheumatology practice. Here such an incidental finding has led to dramatic change in the management of the underlying disease. CASE DESCRIPTION: A 38-year-old gentleman known to have ankylosing spondylitis (AS) since 2008, with radiologically evident sacroilitis on X-ray and MRI, was reviewed routinely in clinic and reported pain and restriction of neck movement and subsequent MRI cervical spine in April 2017 has shown incidental finding of apical fibrosis, but no AS activity. He denied constitutional and respiratory symptoms apart from occasional dry cough. Chest X-ray and high resolution CT scan confirmed the same findings of apical fibrosis in addition to bilateral reticulonodular and fisural changes. Blood tests showed angiotensin converting Eezyme level ACE 65 U/L (normal range 8-65), C-reactive protein <5. Bronchoscopy/biopsy showed non-caseating epitheliod granuloma. ZN stain and culture showed no TB infection. He was reviewed by the respiratory team and felt findings could conceivably fit with sarcoidosis. His dry cough has improved after Benepali was discontinued in June 2017 and no steroids were given. However, had a flare of AS symptoms (ribs and lower back pain and stiffness, right SIJ pain) despite regular etoricoxib and required to start on secukinumab. DISCUSSION: Benepali (Etanercept biosimilar) sounds not different from the originator biologic in causing sarcoid-like reactions commonly present as skin rash and lung lesions. Etanercept is associated with a large majority of reported anti-TNF induced sarcoid-like cases, not effective in treating sarcoidosis and may even exacerbate it. However, there are few reports of adalimumab induced sarcoid-like reactions that resolved when treated with etanercept. Paradoxical reaction to one TNF alfa inhibitor does not preclude the use of other TNF blocking agents including etanercept. KEY LEARNING POINTS: Lung lesions after exposure to anti-TNF warrants investigating a wide range of differential diagnoses. Paradoxical sarcoid-like reactions can occur with anti-TNF treatment and resolves on discounting it. Alternative biologic in ankylosing spondylitis might be a challenge. CONFLICTS OF INTEREST: The authors have declared no conflicts of interest. Oxford University Press 2019-09-26 /pmc/articles/PMC6761446/ http://dx.doi.org/10.1093/rap/rkz029.006 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle POSTER PRESENTATIONS
Saleh, Mohammed
Jenkins, Charlotte
30. The paradox
title 30. The paradox
title_full 30. The paradox
title_fullStr 30. The paradox
title_full_unstemmed 30. The paradox
title_short 30. The paradox
title_sort 30. the paradox
topic POSTER PRESENTATIONS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761446/
http://dx.doi.org/10.1093/rap/rkz029.006
work_keys_str_mv AT salehmohammed 30theparadox
AT jenkinscharlotte 30theparadox